Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.50
-1.60 (-3.01%)
Feb 11, 2026, 1:30 PM CST

Senhwa Biosciences Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-263.96-293.75-296.31-349.63-329.26-354.88
Depreciation & Amortization
12.0812.110.737.116.237.11
Loss (Gain) From Sale of Investments
-6.67-8.68-8.04---
Stock-Based Compensation
---0.641.033.4751.45
Other Operating Activities
-1.38-0.72-1.07-0.25-7.910.22
Change in Accounts Receivable
9.99.99-9.870.19-0.190.03
Change in Accounts Payable
-6.62-10.839.74-52.327.1926.23
Change in Other Net Operating Assets
-1.86-2.341.07-6.120.41-2.84
Operating Cash Flow
-258.5-294.22-294.4-399.97-300.05-272.68
Capital Expenditures
--1.95-4.61-0.37-0.24-0.39
Sale (Purchase) of Intangibles
---0.17--0.16-
Investment in Securities
6.678.688.04---
Other Investing Activities
-0.06-0.02-0.48-0.220.550.01
Investing Cash Flow
6.66.712.79-0.590.15-0.38
Long-Term Debt Issued
-----9.63
Long-Term Debt Repaid
--8.73-8.83-6.31-4.93-5.6
Net Debt Issued (Repaid)
-9.32-8.73-8.83-6.31-4.934.03
Issuance of Common Stock
----6.811,807
Repurchase of Common Stock
----13.24-36.12-1.99
Financing Cash Flow
-9.32-8.73-8.83-19.55-34.241,809
Foreign Exchange Rate Adjustments
-2.023.40.116.67-1.85-4.29
Net Cash Flow
-263.24-292.84-300.33-413.44-3361,531
Free Cash Flow
-258.5-296.17-299-400.34-300.29-273.07
Free Cash Flow Margin
-23935.46%-29617.30%-29900.10%-40034.00%-54597.64%-44257.86%
Free Cash Flow Per Share
-2.90-3.32-3.35-4.49-3.35-3.46
Cash Interest Paid
0.690.660.540.540.530.19
Cash Income Tax Paid
1.761.621.871.36-1.320.41
Levered Free Cash Flow
-147.86-185.82-176.66-273.62-177.76-142.89
Unlevered Free Cash Flow
-147.43-185.41-176.33-273.28-177.43-142.73
Change in Working Capital
1.43-3.170.94-58.2327.4223.42
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.